Skip to main content
Medical information Clinical review pending

Genetic Testing

JUP Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 12 Genetic Test

Genetic test to identify mutations in the JUP gene associated with Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC), a genetic heart condition. Helps assess risk for individuals with relevant family history or symptoms.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (EDTA tube), Extracted DNA, or One drop of blood on an FTA card.
Results
Confirm with the laboratory before booking.
Preparation
A clinical history of the patient is required. A genetic counseling session is recommended prior to testing to discuss the implications and create a family pedigree chart.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the JUP Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 12 Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Family history of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC).
  • ✓Personal history of unexplained syncope (fainting).
  • ✓Personal history of palpitations or other cardiac symptoms suggestive of ARVC.
  • ✓Family history of sudden cardiac death at a young age.
  • ✓Diagnosis of cardiomyopathy where a genetic cause is suspected.
  • ✓Genetic counseling for individuals concerned about inherited heart conditions.
02

In plain language

What this test helps you understand

Identifies genetic mutations in the JUP gene associated with Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC). This information can aid in risk assessment, diagnosis, and management strategies for individuals and families affected by or at risk for ARVC.
The JUP Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 12 NGS Genetic DNA Test is a specialized diagnostic tool used to assess genetic predispositions to Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC). ARVC is a type of inherited heart disease that affects the heart muscle, particularly the right ventricle, and can increase the risk of serious heart rhythm problems and sudden cardiac death. Understanding your genetic risk is important for proactive health management.

This test specifically analyzes the JUP gene, which has been linked to ARVC. By examining your DNA, we can identify specific mutations that may indicate an increased risk for developing this condition.

This test is particularly relevant for individuals with a family history of ARVC, unexplained fainting (syncope), palpitations, or other concerning cardiovascular symptoms. It can provide valuable information for personal health planning and potentially guide screening for family members.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationA clinical history of the patient is required. A genetic counseling session is recommended prior to testing to discuss the implications and create a family pedigree chart.
SampleBlood sample (EDTA tube), Extracted DNA, or One drop of blood on an FTA card.
MethodologyNext Generation Sequencing (NGS) analysis of the JUP gene.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test only analyzes the JUP gene. ARVC can be caused by mutations in other genes. A negative result does not completely rule out ARVC. Results should be interpreted by a qualified healthcare professional.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

ARVC is an inherited heart condition where the heart muscle, especially the right ventricle, is replaced by fatty and fibrous tissue. This can lead to abnormal heart rhythms and potentially sudden cardiac death.
Individuals with a family history of ARVC, unexplained fainting, palpitations, or other heart symptoms, or those with a family history of sudden cardiac death at a young age may benefit from this test.
This test specifically looks for mutations (changes) in the JUP gene, which is known to be associated with an increased risk of developing ARVC.
A healthcare provider, often in consultation with a genetic counselor, will interpret the results. They will discuss whether any mutations were found and what this means for your health and potential risks for family members.
Yes, genetic counseling is highly recommended before and after testing to understand the test's implications, interpret results accurately, and discuss potential risks for family members.
No. This test only looks at the JUP gene. ARVC can be caused by mutations in other genes, or may not have a known genetic cause. A negative result does not completely rule out ARVC.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp